A looming patent cliff is driving Big Pharma reorganization. Executives making career moves must understand differences in ...

The biopharma industry's return on investment in innovation is increasing, but R&D costs are rising, according to a new ...

Transforming Healthcare Through Ayurveda Innovation.Virginia, United States, March 25, 2025 -- In the ever-evolving landscape ...

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

Scientists have unveiled a groundbreaking chemical process that could streamline the development of pharmaceutical compounds, chemical building blocks that influence how drugs interact with the body.

LCS Constructors, a leading general contractor specializing in laboratories and technical facilities, is pleased to announce the appointment of Picasso Bhowmik as Executive Vice President, effective ...

Amid Trump’s dismantling of DEI, Roche wiped diversity targets from the website of its US subsidiary, Genentech, in mid-February. Basel-based competitor Novartis also said this week it was getting rid ...

Our interdisciplinary school is leading scientific exploration and engineering expertise in sustainability solutions, biomedical innovation and advanced materials. We address crucial issues like ...

Quantumzyme Corp., a pioneering biotechnology company specializing in computational enzyme engineering, is pleased to introduce our Chief Executive Officer (CEO) and Director, Mr. Naveen Kulkarni ("Mr ...

A generic product cannot enter the market until the originator product’s IP has expired, but the development process can take ...